Back

mRNA vaccines for COVID-19 are safe and effective in patients with cardiac amyloidosis

21 May 2023 (14:00 - 15:00)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease 2 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Gina Barzen

Charité - University Medicine Berlin, Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
The risk of cardiac hospitalization and arrythmias in patients with arrhythmogenic and dilated cardiomyopathies
Doctor M. Marques Antunes (Lisboa, PT)
Abstract Slides
Presentation thumbnail
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance
Doctor L. De Michieli (Padova, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of left ventricular global longitudinal strain in patients with hypertrophic cardiomyopathy
Assistant Professor O. Butko (Kharkiv, UA)
Abstract Slides
Presentation thumbnail
Analysis of a novel myocardial functional echocardiographic parameter, left ventricular myocardial work, in patients with hyperthrophic cardiomyopathy
Doctor G. Racz (Stavanger, NO)
Abstract Slides
Presentation thumbnail
The kinetic of left ventricle diastolic dysfunction during pharmacotherapy up-titration in patients with dilated cardiomyopathy.
Doctor E. Dziewiecka (Krakow, PL)
Abstract Slides

Access the full session

Session thumbnail
ePosters in myocardial disease 2

The Event

Event poster

Heart Failure 2023

21 May 2023 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources